Clinical Trial Update: Immunogenicity, Safety and Tolerability of the Typhoid Fever Vaccine Candidate M01ZH09 in Healthy Adults [Phase 2]

View source ↗

Summary

Phase 2 trial reports on immunogenicity, safety, and tolerability of the typhoid fever vaccine candidate M01ZH09 in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Typhoid Fever

Drugs mentioned

• M01ZH09

Snippet

Sponsor: Emergent BioSolutions | Conditions: Typhoid | Phase 2 | Status: COMPLETED | Results posted: 2017-06-07